Cargando…
An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
Archaeosomes constitute archaeal lipid vesicle vaccine adjuvants that evoke a strong CD8(+) T cell response to antigenic cargo. Therapeutic treatment of murine B16-ovalbumin (B16-OVA) melanoma with archaeosome-OVA eliminates small subcutaneous solid tumors; however, they eventually resurge despite a...
Autores principales: | Stark, Felicity C., Weeratna, Risini D., Deschatelets, Lise, Gurnani, Komal, Dudani, Renu, McCluskie, Michael J., Krishnan, Lakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748605/ https://www.ncbi.nlm.nih.gov/pubmed/29072624 http://dx.doi.org/10.3390/vaccines5040038 |
Ejemplares similares
-
The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
por: Jia, Yimei, et al.
Publicado: (2021) -
Archaeosome Adjuvant Overcomes Tolerance to Tumor-Associated Melanoma Antigens Inducing Protective CD8(+) T Cell Responses
por: Krishnan, Lakshmi, et al.
Publicado: (2010) -
Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity
por: McCluskie, Michael J., et al.
Publicado: (2017) -
Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2019) -
Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
por: Jia, Yimei, et al.
Publicado: (2022)